[Separation of the divalent Ca++ antagonistic effect component from the beta-adrenolytic effects of cardio-depressive drugs on cultures of embryonic heart muscle cells].
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001696:Biomechanical Phenomena; D002118:Calcium / Q000037:antagonists & inhibitors*; D002642:Chick Embryo; D046508:Culture Techniques; D003864:Depression, Chemical; D006321:Heart / Q000187:drug effects* / Q000196:embryology / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D009570:Nitriles / Q000494:pharmacology*; D011299:Prenylamine / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D014700:Verapamil; D011299:Prenylamine; D002118:Calcium
Trennung der Ca-antagonistischen Wirkungskomponente von den beta-adrenolytischen Effekten Herz-hemmender Pharmaka an Kulturen embryonaler Herzmuskelzellen.